Microfluidic Immunoassay Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Microfluidic Immunoassay Market covers analysis By Product Type (Microfluidic Diagnostics, Other Quantifiable POC Diagnostics); Technology (Point of Care Lab on Chip Technology, Non Lab on Chip Point of Care Technology); Application (Cardiac Biomarker Detection, Inflammatory Biomarker Detection, Other Biomarkers) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00016759
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



The immunoassay is a kind of biochemical test which measures the concentration of small molecules in a solution by using antigen or antibody. The molecule which is detected through this test is referred to as a analyte. Microfluidic immunoassay is a new technique in immunoassays which uses microfluidic chip into it and provides more sensitivity and accuracy in results.

MARKET DYNAMICS



The key market drivers for Microfluidic Immunoassay Market Includes, quick results of the tests with high precision along with innovative technologies in microfluidic immunoassay are the factors which are expected to drive market growth during the forecast period. However, problems with reproducibility of test is a factor expected to restrain market growth during the forecast period.

MARKET SCOPE



The "Microfluidic Immunoassay Market" is a specialized and in-depth study of the Medical Device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Microfluidic Immunoassay market with detailed market segmentation by product type, technology and application. The Microfluidic Immunoassay Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Microfluidic Immunoassay Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The Microfluidic Immunoassay Market is segmented on the basis of product type, technology and application. On the basis of product type the market is segmented into, microfluidic diagnostics, other quantifiable POC diagnostics. On the basis of technology the market is segmented into, point of care lab on technology and non-lab on chip point of table technology. On the basis of application the market is segmented into, cardiac biomarker detection, inflammatory biomarker decision and other biomarker detection.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Microfluidic Immunoassay Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Microfluidic Immunoassay Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Microfluidic Immunoassay Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Microfluidic Immunoassay Market in these regions.

MARKET PLAYERS



The report covers key developments in the Microfluidic Immunoassay Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Microfluidic Immunoassay Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Microfluidic Immunoassay market in the global market. Below mentioned is the list of few companies engaged in the Microfluidic Immunoassay Market.

The report also includes the profiles of key players in Microfluidic Immunoassay Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Abaxis,Inc
  •   Nanomix,Inc
  •   Abbott Laboratories
  •   Koninklijke Philips N.V
  •   Biosurfit SA
  •   Micropoint Bioscience,Inc
  •   Siloam Biosciences
  •   NanoEnTek Inc
  •   OPKO Health,Inc
  •   Quidel Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Microfluidic Immunoassay Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Microfluidic Diagnostics
  • Other Quantifiable POC Diagnostics
By Technology
  • Point of Care Lab on Chip Technology
  • Non Lab on Chip Point of Care Technology
By Application
  • Cardiac Biomarker Detection
  • Inflammatory Biomarker Detection
  • Other Biomarkers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abaxis, Inc
  • Nan
  • mix, Inc
  • Abbott Laboratories
  • Koninklijke Philips N.V
  • Biosurfit SA
  • Micropoint Bioscience, Inc
  • Siloam Biosciences
  • NanoEnTek Inc.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Abaxis, Inc
    2. Nan- mix, Inc
    3. Abbott Laboratories
    4. Koninklijke Philips N.V
    5. Biosurfit SA
    6. Micropoint Bioscience, Inc
    7. Siloam Biosciences
    8. NanoEnTek Inc.
    9. OPKO Health, Inc
    10. Quidel Corporation
    Buy Now